Trichostatin A enhances glutamate transporter GLT-1 mRNA levels in c6 glioma cells via neurosteroid-mediated cell differentiation

Journal of Molecular Neuroscience

Volumn 49, Issue 1, 2013, Pages 21-27

  Itoh, Mari ^a   Hiroi, Takara ^a   Nishibori, Naoyoshi ^b   Sagara, Takefumi ^b   Her, Song ^c   Lee, Mi Sook ^c   Morita, Kyoji ^a  

^a SHIKOKU UNIVERSITY   (Japan)

^b Shikoku Junior College   (Japan)

^c Korea Basic Science Institute (KBSI)   (South Korea)

Author keywords

Excitotoxic damage; Glial cell differentiation; GLT 1 gene expression; Neuroprotective function; Trichostatin A

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; SODIUM GLUCOSE COTRANSPORTER 1; STEROID 5ALPHA REDUCTASE; TRICHOSTATIN A;

ANIMAL CELL; ARTICLE; CELL LEVEL; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLIA CELL; GLIOMA CELL; NERVE CELL DIFFERENTIATION; NONHUMAN; RAT;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHOLESTENONE 5 ALPHA-REDUCTASE; EXCITATORY AMINO ACID TRANSPORTER 2; EXCITATORY AMINO ACIDS; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; HISTONE DEACETYLASE INHIBITORS; HYDROXAMIC ACIDS; NEUROGLIA; NEUROTRANSMITTER AGENTS; RATS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UP-REGULATION;

RATTUS;

EID: 84871991617     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-012-9842-1     Document Type: Article

References (33)

1. Allritz C, Bette S, Figiel M, Engele J (2009) Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels. Neurochem Int 55:22-27
2. Asbury ET, Fritts ME, Horton JE, Isaac WL (1998) Progesterone facilitates the acquisition of avoidance learning and protects against subcortical neuronal death following prefrontal cortex ablation in the rat. Behav Brain Res 97:99-106
3. Beart PM, O'Shea RD (2007) Transporters for l-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 150:5-17
4. Bova R, Micheli MR, Qualadrucci P, Zucconi GG (1998) BDNF and trkB mRNAs oscillate in rat brain during the light-dark cycle. Mol Brain Res 57:321-324
5. Callier S, Morissette M, Grandbois M, Pe'laprat D, Di Paolo T (2001) Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57Bl/6 mice. Synapse 41:131-138
6. Caudle WM, Zhang J (2009) Glutamate, excitotoxicity, and programmed cell death in Parkinson disease. Exp Neurol 220:230-233
7. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
8. Comer AM, Yip S, Lipski J (1997) Detection of weakly expressed genes in the rostral ventrolateral medulla of the rat using micropunch and reverse transcription-polymerase chain reaction techniques. Clin Exp Pharmacol Physiol 24:755-759
9. Corona JC, Tovar-y-Romo LB, Tapia R (2007) Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis. Expert Opin Ther Targets 11:1415-1428
10. Cowan CM, Raymond LA (2006) Selective neuronal degeneration in Huntington's disease. Curr Top Dev Biol 75:25-71
11. Her S, Lee MS, Morita K (2010) Trichostatin A stimulates steroid 5alpha-reductase gene expression in rat C6 glioma cells via a mechanism involving Sp1 and Sp3 transcription factors. J Mol Neurosci 41:252-262
12. Kaur P, Jodhka PK, Underwood WA, Bowles CA, de Fiebre NC, de Fiebre CM, Singh M (2007) Progesterone increases brain-derived neurotrophic factor expression and protects against glutamate toxicity in a mitogen-activated protein kinase- and phosphoinositide-3 kinase-dependent manner in cerebral cortical explants. J Neurosci Res 85:2441-2449
13. Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, Dasgupta S, Barral PM, Hedvat M, Diaz P, Reed JC, Stebbins JL, Pellecchia M, Sarkar D, Fisher PB (2011) Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J Cell Physiol 226:248-293
14. Koutsilieri E, Riederer P (2007) Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease. Parkinsonism Relat Disord 13:S329-S331
15. Mattson MP (2003) Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromol Med 3:65-94
16. Mennini T, Fumagalli E, Gobbi M, Fattorusso C, Catalanotti B, Campiani G (2003) Substrate inhibitors and blockers of excitatory amino acid transporters in the treatment of neurodegeneration: critical considerations. Eur J Pharmacol 479:291-296
17. Morikawa M, Asai K, Kokubo M, Fujita K, Yoneda K, Yamamoto N, Inoue Y, Iida J, Kishimoto T, Kato T (2001) Isolation and characterization of a new immortal rat astrocyte with a high expression of NGF mRNA. Neurosci Res 39:205-212
18. Morita K, Her S (2008) Progesterone pretreatment enhances serotonin-stimulated BDNF gene expression in rat C6 glioma cells through production of 5α-reduced neurosteroids. J Mol Neurosci 34:193-200
19. Morita K, Tsuruo Y, Ishimura K, Her S, Bell RA, Wong DL (1999) Influence of serum-free culture conditions on steroid 5α-reductase mRNA expression in rat C6 glioma cells. Brain Res 830:179-182
20. Morita K, Arimochi H, Itoh H, Her S (2006) Possible involvement of 5α-reduced neurosteroids in adrenergic and serotonergic stimulation of GFAP gene expression in rat C6 glioma cells. Brain Res 1085:49-56
21. Morita K, Gotohda T, Arimochi H, Lee M-S, Her S (2009) Histone deacetylase inhibitors promote neurosteroid-mediated cell differentiation and enhance serotonin-stimulated BDNF gene expression in rat C6 glioma cells. J Neurosci Res 87(11):2608-2614
22. Nilsen J, Brinton RD (2002) Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinol 143:205-212
23. Nilsen J, Brinton RD (2003) Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling. Proc Natl Acad Sci U S A 100:10506-10511
24. Rauen T, Taylor WR, Kuhlbrodt K, Wiessner M (1998) High-affinity glutamate transporters in the rat retina: a major role of the glial glutamate transporter GLAST-1 in transmitter clearance. Cell Tissue Res 291:19-31
25. Roof RL, Duvdevani R, Braswell L, Stein DG (1994) Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol 129:64-69
26. Roof RL, Hoffman SW, Stein DG (1997) Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol 31:1-11
27. Schroeder FA, Lin CL, Crusio WE, Akbarian S (2007) Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62:55-64
28. Sowa Y, Orita T, Hiranabe-Minamikawa S, Nakano K, Mizuno T, Nomura H, Sakai T (1999) Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites. Ann N Y Acad Sci 886:195-199
29. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519-525
30. Van Lint C, Emiliani S, Verdin E (1996) The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 5:245-253
31. Vigushin DM, Coombes RC (2004) Targeted histone deacetylase inhibition for cancer therapy. Curr Cancer Drug Targets 4:205-218
32. Vigushin DM, Ali S, Pace PE, Mirsaidi N, Ito K, Adcock I, Coombes RC (2001) Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res 7:971-976
33. Vucic S, Kiernan MC (2009) Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis. Curr Mol Med 9:255-272